Manages pain severe enough to require an opioid analgesic. ANDA 211825, held by Unichem. Tramadol Hydrochloride.
As of Nov 16, 2026, ANDA 211825 (Tramadol Hydrochloride), held by Unichem, was first approved by FDA on Aug 9, 2019, with 10 approved supplements and 0 published complete response letters.
Tramadol hydrochloride tablets are indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics, including tramadol hydrochloride, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain ( 1, 5.1 ).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 9, 2019 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tramadol Hydrochloride50MG · tablet;oral | Tramadol Hydrochloride | Rx |
| Jun 18, 2026 | Supplement 22REMS | Approved | None posted |
| Feb 13, 2026 | Supplement 21Labeling · Standard review | Approved | None posted |
| Feb 13, 2026 | Supplement 16Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 15REMS | Approved | None posted |
| Dec 15, 2023 | Supplement 14Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 13Labeling · Standard review | Approved | None posted |
| Nov 30, 2023 | Supplement 12Labeling · Standard review | Approved | None posted |
| Nov 30, 2023 | Supplement 8Labeling · Standard review | Approved | None posted |
| Nov 30, 2023 | Supplement 5Labeling · Standard review | Approved | None posted |
| May 11, 2020 | Supplement 2Labeling · Standard review | Approved | None posted |
| Aug 9, 2019 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters